Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan P Million

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Reviews. Drug Discovery|May 16, 2006
Impact of genetic diagnostics on drug development strategyRyan P Million
Nature Reviews. Drug Discovery|December 19, 2015
Monoclonal antibody biosimilarsNatasha Udpa, Ryan P Million
Nature Reviews. Drug Discovery|December 2, 2011
Personalized medicine in oncology: next generationAlex Chiang, Ryan P Million
Nature Reviews. Drug Discovery|August 15, 2015
Trends in breakthrough therapy designationRachel R Chizkov, Ryan P Million
Nature Reviews. Drug Discovery|August 31, 2013
The epigenetics pipelineVivian A DeWoskin, Ryan P Million
Nature Reviews. Drug Discovery|August 24, 2007
Tapping the potential of fixed-dose combinationsTara M Herrick, Ryan P Million
Nature Reviews. Drug Discovery|January 1, 2015
Targeting the IL-17-T(H)17 pathwayHilary S Bartlett, Ryan P Million
Nature Reviews. Drug Discovery|April 2, 2009
Allergic rhinitis: market evolutionMatthew J Clark, Ryan P Million
Nature Reviews. Drug Discovery|March 29, 2013
Antibody-drug conjugatesRachel S Zolot, Satarupa Basu, Ryan P Million
Blood|May 31, 2002
The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in miceRyan P Million, Jon Aster, D Gary Gilliland, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Reviews. Drug Discovery|May 16, 2006
Impact of genetic diagnostics on drug development strategyRyan P Million
Nature Reviews. Drug Discovery|December 19, 2015
Monoclonal antibody biosimilarsNatasha Udpa, Ryan P Million
Nature Reviews. Drug Discovery|December 2, 2011
Personalized medicine in oncology: next generationAlex Chiang, Ryan P Million
Nature Reviews. Drug Discovery|August 15, 2015
Trends in breakthrough therapy designationRachel R Chizkov, Ryan P Million
Nature Reviews. Drug Discovery|August 31, 2013
The epigenetics pipelineVivian A DeWoskin, Ryan P Million
Nature Reviews. Drug Discovery|August 24, 2007
Tapping the potential of fixed-dose combinationsTara M Herrick, Ryan P Million
Nature Reviews. Drug Discovery|January 1, 2015
Targeting the IL-17-T(H)17 pathwayHilary S Bartlett, Ryan P Million
Nature Reviews. Drug Discovery|April 2, 2009
Allergic rhinitis: market evolutionMatthew J Clark, Ryan P Million
Nature Reviews. Drug Discovery|March 29, 2013
Antibody-drug conjugatesRachel S Zolot, Satarupa Basu, Ryan P Million
Blood|May 31, 2002
The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in miceRyan P Million, Jon Aster, D Gary Gilliland, et al.
Pageof 2